Epidemiology and molecular evolution of GI.1 sapovirus in the recent era.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
Sep 2024
Historique:
revised: 25 08 2024
received: 02 06 2024
accepted: 27 08 2024
medline: 12 9 2024
pubmed: 12 9 2024
entrez: 12 9 2024
Statut: ppublish

Résumé

Sapovirus (SaV) infection is increasing worldwide. Herein, we provided evidence of a significant increase in SaV infection in Japan during 2010-2022, primarily due to the considerable (p = 0.0003) rise of the GI.1 genotype. Furthermore, we found that all major and minor SaV outbreaks in Japan, including the largest SaV outbreak in 2021-2022, were caused by the GI.1 genotype. Therefore, to get insight into the underlying molecular mechanism behind this rising trend of the SaV GI.1 type, we selected 15 SaV GI.1 outbreak strains for complete genome analysis through next-generation sequencing. Phylogenetically, our strains remained clustered in different branches in lineages I and II among the GI.1 genotype. We showed all amino acid (aa) substitutions in different open reading frames (ORFs) in these strains. Importantly, we have demonstrated that the strains involved in the largest SaV outbreak in Japan in 2021-2022 belonged to lineage II and possessed the third ORF. We have identified some unique aa mutations in these major outbreak strains in the NS1 and NS6-NS7 regions that are thought to be associated with viral pathogenicity, cell tropism, and epidemiological competence. Thus, in addition to enriching the database of SaV's complete sequences, this study provides insights into its important mutations.

Identifiants

pubmed: 39264064
doi: 10.1002/jmv.29904
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29904

Subventions

Organisme : Grants-in-Aid for Japan Agency for Medical Research and Development (AMED)
ID : JP23fk0108668
Organisme : Grants-in-Aid for Japan Agency for Medical Research and Development (AMED)
ID : JP24fk0108668
Organisme : Japan Society for the Promotion of Science (JSPS)
ID : 24K11007
Organisme : Research Center for GLOBAL and LOCAL Infectious Diseases, Oita University
ID : 2024B02

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Oka T, Yamamoto SP, Iritani N, et al. Polymerase chain reaction primer sets for the detection of genetically diverse human sapoviruses. Arch Virol. 2020;165(10):2335‐2340.
de Oliveira‐Tozetto S, Santiso‐Bellón C, Ferrer‐Chirivella JM, et al. Epidemiological and genetic characterization of sapovirus in patients with acute gastroenteritis in valencia (Spain). Viruses. 2021;13(2):184.
Hoque SA, Thongprachum A, Takanashi S, et al. Alarming situation of spreading enteric viruses through sewage water in Dhaka city: molecular epidemiological evidences. Food Environ Virol. 2019;11(1):65‐75.
Oka T, Wang Q, Katayama K, Saif LJ. Comprehensive review of human sapoviruses. Clin Microbiol Rev. 2015;28(1):32‐53.
Oka T, Lu Z, Phan T, Delwart EL, Saif LJ, Wang Q. Genetic characterization and classification of human and animal sapoviruses. PLoS One. 2016;11(5):e0156373.
George UE, Faleye TOC, De Coninck L, et al. Metagenomic detection and genetic characterization of human sapoviruses among children with acute flaccid paralysis in Nigeria. Pathogens. 2024;13(3):264.
Oka T, Katayama K, Ogawa S, et al. Proteolytic processing of sapovirus ORF1 polyprotein. J Virol. 2005;79(12):7283‐7290.
Clarke IN, Lambden PR. Organization and expression of calicivirus genes. J Infect Dis. 2000;181(suppl 2):S309‐S316.
Ji X, Guo C, Dai Y, et al. Genomic characterization and molecular evolution of sapovirus in children under 5 years of age. Viruses. 2024;16(1):146.
Smertina E, Hall RN, Urakova N, Strive T, Frese M. Calicivirus non‐structural proteins: potential functions in replication and host cell manipulation. Front Microbiol. 2021;12:712710.
Kumthip K, Khamrin P, Ushijima H, Chen L, Li S, Maneekarn N. Genetic recombination and diversity of sapovirus in pediatric patients with acute gastroenteritis in Thailand, 2010–2018. PeerJ. 2020;8:e8520.
Dos Anjos K, Lima LMP, Silva PA, Inoue‐Nagata AK, Nagata T. The possible molecular evolution of sapoviruses by inter‐ and intra‐genogroup recombination. Arch Virol. 2011;156(11):1953‐1959.
Tohma K, Kulka M, Coughlan S, Green KY, Parra GI. Genomic analyses of human sapoviruses detected over a 40‐year period reveal disparate patterns of evolution among genotypes and genome regions. Viruses. 2020;12(5):516.
Hemming M, Räsänen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into The National immunization programme in Finland. Eur J Pediatr. 2013;172(6):739‐746.
Doll MK, Gagneur A, Tapiéro B, et al. Temporal changes in pediatric gastroenteritis after rotavirus vaccination in Quebec. Pediatr Infect Dis J. 2016;35(5):555‐560.
Koo HL, Neill FH, Estes MK, et al. Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination. J Pediatric Infect Dis Soc. 2013;2(1):57‐60.
Hoque SA, Nishimura K, Thongprachum A, et al. An increasing trend of human sapovirus infection in Japan, 2009 to 2019: an emerging public health concern. J Infect Public Health. 2022;15(3):315‐320.
Hoque SA, Iizuka I, Kobayashi M, et al. Determining effectiveness of rotavirus vaccine by immunochromatography and reverse transcriptase polymerase chain reaction: a comparison. Vaccine. 2019;37(39):5886‐5890.
Kawata K. Role of rotavirus vaccination on G9P[8] rotavirus strain during a seasonal outbreak in Japan. Hum Vaccin Immunother. 2021;17:1‐6.
Hoque SA, Islam MT, Kobayashi M, et al. Our response to the letter to the editor. Vaccine. 2018;36(34):5110‐5111.
Ushijima H, Hikita T, Kobayashi M, et al. The detection of rotavirus antigenemia by immunochromatographic kits: a case series. Clin Lab. 2021;67(10).
Hoque SA, Wakana A, Shimizu H, et al. Detection of rotavirus strains in freshwater clams in Japan. Food Environ Virol. 2022;14(1):94‐100.
Okitsu S, Khamrin P, Hikita T, et al. Changing distribution of rotavirus A genotypes circulating in Japanese children with acute gastroenteritis in outpatient clinic, 2014–2020. J Infect Public Health. 2022;15(7):816‐825.
Hoque SA, Pham NTK, Onda‐Shimizu Y, et al. Sapovirus infections in Japan before and after the emergence of the COVID‐19 pandemic: an alarming update. J Med Virol. 2023;95(8):e29023.
Thongprachum A, Khamrin P, Pham NTK, et al. Multiplex RT‐PCR for rapid detection of viruses commonly causing diarrhea in pediatric patients. J Med Virol. 2017;89(5):818‐824.
Fukuda S, Akari Y, Hatazawa R, et al. Rapid spread in Japan of unusual G9P[8] human rotavirus strains possessing NSP4 genes of E2 genotype. Jpn J Infect Dis. 2022;75(5):466‐475.
Ushijima H, Hoque SA, Akari Y, et al. Molecular evolution of GII.P31/GII.4_Sydney_2012 norovirus over a decade in a clinic in Japan. Int J Mol Sci. 2024;25(7):3619.
Moraes MTB, Leitão GAA, Olivares AIO, et al. Molecular epidemiology of sapovirus in children living in the northwest Amazon region. Pathogens. 2021;10(8):965.
Svraka S, Vennema H, van der Veer B, et al. Epidemiology and genotype analysis of emerging sapovirus‐associated infections across Europe. J Clin Microbiol. 2010;48(6):2191‐2198.
Jiao Y, Han T, Qi X, et al. Genotypes diversity of acute gastroenteritis outbreaks caused by human sapovirus—Beijing municipality, China, 2015–2021. China CDC Weekly. 2023;5(28):625‐631.
Zhuo R, Ding X, Freedman SB, et al. Molecular epidemiology of human sapovirus among children with acute gastroenteritis in Western Canada. J Clin Microbiol. 2021;59(10):e0098621.
Phengma P, Khamrin P, Jampanil N, et al. Molecular epidemiology and characterization of norovirus and sapovirus in pediatric patients with acute diarrhea in Thailand, 2019–2020. J Infect Public Health. 2022;15(9):1013‐1019.
Doan YH, Yamashita Y, Shinomiya H, et al. Distribution of human sapovirus strain genotypes over the last four decades in Japan: a global perspective. Jpn J Infect Dis. 2023;76(4):255‐258.
Oka T, Mori K, Iritani N, et al. Human sapovirus classification based on complete capsid nucleotide sequences. Arch Virol. 2012;157(2):349‐352.

Auteurs

Sheikh A Hoque (SA)

Department of Pathology and Microbiology, Nihon University School of Medicine, Division of Microbiology, Tokyo, Japan.
Cell and Tissue Culture Laboratory, Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka, Bangladesh.

Yuki Akari (Y)

Department of Virology, Fujita Health University School of Medicine, Toyoake, Japan.

Pattara Khamrin (P)

Department of Microbiology, Faculty of Medicine, and Emerging and Re-emerging Diarrheal Viruses Research Center, Chiang Mai University, Chiang Mai, Thailand.

Tung Phan (T)

Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Yuko Onda (Y)

Department of Pathology and Microbiology, Nihon University School of Medicine, Division of Microbiology, Tokyo, Japan.

Shoko Okitsu (S)

Department of Pathology and Microbiology, Nihon University School of Medicine, Division of Microbiology, Tokyo, Japan.

Satoshi Komoto (S)

Department of Virology, Fujita Health University School of Medicine, Toyoake, Japan.
Center for Infectious Disease Research, Research Promotion Headquarters, Fujita Health University, Toyoake, Japan.
Research Center for GLOBAL and LOCAL Infectious Diseases, Division of One Health, Oita University, Yufu, Japan.

Satoshi Hayakawa (S)

Department of Pathology and Microbiology, Nihon University School of Medicine, Division of Microbiology, Tokyo, Japan.

Shihoko Komine-Aizawa (S)

Department of Pathology and Microbiology, Nihon University School of Medicine, Division of Microbiology, Tokyo, Japan.

Yoshikazu Yuki (Y)

Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.
Research Institute of Disaster Medicine, Institute for Global Prominent Research, Institute for Advanced Academic Research, Chiba University, Chiba, Japan.
Department of Medicine, CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Division of Gastroenterology, University of California, San Diego, California, USA.

Hiroshi Kiyono (H)

Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.
Research Institute of Disaster Medicine, Institute for Global Prominent Research, Institute for Advanced Academic Research, Chiba University, Chiba, Japan.
Department of Medicine, CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Division of Gastroenterology, University of California, San Diego, California, USA.

Hiroshi Ushijima (H)

Department of Pathology and Microbiology, Nihon University School of Medicine, Division of Microbiology, Tokyo, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH